ATP1B1 and neurodevelopmental disorder: In addition, deletions of MYO16 and ATP1B genes have been also noted in additional unrelated patients with neurodevelopmental disorders (NDDs) in other published studies (Table 3) ([8–10] and see acknowledgments for details).